The Medical Advisor

Introduction Cancer care is evolving beyond a narrow focus on tumor destruction toward a more comprehensive model that considers metabolism, immunity, inflammation, and quality of life. Within this broader framework, nutritional pharmacology—the use of nutrients at pharmacological doses to influence biological pathways—has gained renewed interest. Proponents argue that certain nutrients, when administered at doses far exceeding dietary intake, may exert effects comparable to drugs: modulating oxidative stress, immune function, angiogenesis, and tumor metabolism. Critics counter that enthusiasm has outpaced evidence. The truth likely lies between these positions. This article examines the scientific rationale, clinical evidence, and limitations of nutritional pharmacology in cancer care, with particular attention to high-dose intravenous vitamin C , the most extensively studied example. What Is Nutritional Pharmacology? Nutritional pharmacology differs fundamentally from conventiona...

Dr. William Makis MD (McGill Medicine, 110+ peer-reviewed publications) runs the world's largest high-dose ivermectin cancer clientele in 2025 – he has guided thousands of patients globally with remarkable results in turbo cancers and conventional failures. This continuously updated 2026 guide compiles Dr. Makis's latest protocols (from his Substack, X posts through 2026, and direct patient correspondence). We cross-reference his exact dosages, schedules, combinations, safety data, sourcing, and real patient outcomes (anonymized but verifiable on his channels). Important Disclaimer: This content is for educational purposes only and does not constitute medical advice. Ivermectin is used off-label for cancer treatment. Always consult with a knowledgeable physician whom you trust to manage your health. Individual results may vary. Do not self-medicate with ivermectin without proper bloodwork and medical monitoring, as misuse can lead to serious side effects and drug interactions. ...

For years, insulin resistance has been framed as a “carbohydrate problem.” Cut carbs. Avoid insulin spikes. Control blood sugar. But this framing is incomplete — and in many cases, misleading. Insulin resistance is not simply a response to eating carbohydrates. It is a systems-level metabolic dysfunction rooted in impaired cellular signaling, mitochondrial stress, chronic hyperinsulinemia, and metabolic inflexibility. If we want to understand diabetes, obesity, cardiovascular disease, accelerated aging — and even cancer risk — we need to look deeper than glucose. We need to look inside the cell. What Is Insulin Resistance — Really? Insulin resistance is a condition where cells (primarily muscle, liver, and adipose tissue) become less responsive to insulin’s signal. Under healthy conditions: Insulin helps shuttle glucose into cells. Mitochondria efficiently convert fuel into ATP. Cells switch flexibly between burning carbohydrates and fats. When insulin resistance develops: Cells stop r...

Contents: Editor's Preface Introduction Fenbendazole Case Series Compilation (alphabetical) Breast Cancer Success Stories  (70 cases) Brain Cancer (including Glioblastoma) (116 cases) Bile Duct Cancer (Cholangiocarcinoma)  (4 cases) Bladder Cancer Success Stories  (including kidney cancer) (29 cases) Cervical Cancer  (2 cases) Colorectal Cancer  (including Appendix cancer) (51 cases) Esophageal and Stomach cancer (20 cases) Endometrial Cancer (9 cases) Gastric (Stomach) cancer (see  Esophageal and Stomach Cancer ) (19 cases) Head and Neck Cancer (15 cases) Kidney Cancer Case Series  (including urinary (urothelial) bladder cancer) (27 cases) Liver Cancer (HepatoCellular Cancer)  (3 cases) Lung Cancer (36 cases) Leukemia (9 cases) Lymphoma (20 cases) Melanoma (refer to Skin Cancer ) Mul...